Publication: Drug resistant falciparum malaria: Clinical consequences and strategies for prevention
Issued Date
2001-01-01
Resource Type
ISSN
13687646
Other identifier(s)
2-s2.0-0035180748
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Drug Resistance Updates. Vol.4, No.3 (2001), 187-196
Suggested Citation
R. N. Price, F. Nosten Drug resistant falciparum malaria: Clinical consequences and strategies for prevention. Drug Resistance Updates. Vol.4, No.3 (2001), 187-196. doi:10.1054/drup.2001.0195 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/26488
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Drug resistant falciparum malaria: Clinical consequences and strategies for prevention
Author(s)
Other Contributor(s)
Abstract
The rising prevalence of multidrug resistant falciparum malaria is occurring at an alarming rate and has serious implications for the health of many of the world's poorest countries. The dangers of not changing treatment practices immediately are huge and irreversible, threatening to both exacerbate the scale and scope of the malaria pandemic, and deprive policymakers of future options against the disease. If a health care disaster is to be avoided then massive and long term funding is urgently required. Funds need to be applied in a cohesive manner, accountable to funding bodies and tailored to the specifics of each endemic region. The key elements of such an approach should be improving early diagnosis and treatment of infection and the deployment of combination regimens containing an artemisinin derivative. These short term measures will need to be accompanied by a longer term strategy to encourage antimalarial drug research and development. © 2001 Harcourt Publishers Ltd.